Zimmer Biomet (ZBH) is witnessing volume improvement within Knee and Hip businesses. However, macroeconomic issues impede growth. The stock carries a Zacks Rank #3 (Hold) currently. Zimmer Biomet has witnessed a rebound in its business in the past few quarters despite macroeconomic challenges. According to the company, procedure recovery continues, aided by no meaningful impact from staffing challenges. Accordingly, the company is enjoying a tailwind from increased provider capacity, resulting in backlog pu ...